Back
4D Molecular Therapeutics Vs. Karyopharm Therapeutics Industry Stock Comparison
Sell
50
FDMT
4D Molecular Therapeutics
Last Price:
26.18
Seasonality Move:
-18.33%
Sell
44
KPTI
Karyopharm Therapeutics
Last Price:
1.04
Seasonality Move:
-3.19%
Sell
50
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $26.33. The Score for FDMT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.02. The Score for KPTI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $26.33
The current trend is relatively stagnant and FDMT is experiencing slight selling pressure.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 49.49 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.54 - 27.44) | Buy |
| Bollinger Bands (100): | (20.1 - 30.08) | Buy |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 39.64 | Sell |
| Chaikin Money Flow: | -2636223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.28) | Sell |
| Bollinger Bands (100): | (0.88 - 1.4) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.77 | Buy |
| 20-day SMA: | 25.54 | Buy |
| 50-day SMA: | 28.22 | Sell |
| 200-day SMA: | 19.48 | Buy |
| 8-day EMA: | 25.99 | Buy |
| 20-day EMA: | 26.14 | Buy |
| 50-day EMA: | 26.51 | Sell |
| 200-day EMA: | 21.85 | Buy |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 1.16 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.14 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.45 | Sell |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.08 per share, an increase this year of $0.02 per share, and an increase next year of $0.17 per share.
4D Molecular Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||